165 related articles for article (PubMed ID: 29800703)
1. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract][Full Text] [Related]
2. Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.
Shaashua L; Shabat-Simon M; Haldar R; Matzner P; Zmora O; Shabtai M; Sharon E; Allweis T; Barshack I; Hayman L; Arevalo J; Ma J; Horowitz M; Cole S; Ben-Eliyahu S
Clin Cancer Res; 2017 Aug; 23(16):4651-4661. PubMed ID: 28490464
[No Abstract] [Full Text] [Related]
3. Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial.
Haldar R; Ricon-Becker I; Radin A; Gutman M; Cole SW; Zmora O; Ben-Eliyahu S
Cancer; 2020 Sep; 126(17):3991-4001. PubMed ID: 32533792
[TBL] [Abstract][Full Text] [Related]
4. Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.
Sorski L; Melamed R; Matzner P; Lavon H; Shaashua L; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2016 Nov; 58():91-98. PubMed ID: 27235931
[TBL] [Abstract][Full Text] [Related]
5. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
Glasner A; Avraham R; Rosenne E; Benish M; Zmora O; Shemer S; Meiboom H; Ben-Eliyahu S
J Immunol; 2010 Mar; 184(5):2449-57. PubMed ID: 20124103
[TBL] [Abstract][Full Text] [Related]
6. Perioperative escape from dormancy of spontaneous micro-metastases: A role for malignant secretion of IL-6, IL-8, and VEGF, through adrenergic and prostaglandin signaling.
Haldar R; Berger LS; Rossenne E; Radin A; Eckerling A; Sandbank E; Sloan EK; Cole SW; Ben-Eliyahu S
Brain Behav Immun; 2023 Mar; 109():175-187. PubMed ID: 36646396
[TBL] [Abstract][Full Text] [Related]
7. Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats.
Benjamin B; Hazut O; Shaashua L; Benish M; Zmora N; Barshack I; Hoffman A; Ben-Eliyahu S; Zmora O
Int J Colorectal Dis; 2010 Dec; 25(12):1459-64. PubMed ID: 20556396
[TBL] [Abstract][Full Text] [Related]
8. A window-of-opportunity biomarker study of etodolac in resectable breast cancer.
Schwab RB; Kato S; Crain B; Pu M; Messer K; Weidner N; Blair SL; Wallace AM; Carson DA; Parker BA
Cancer Med; 2015 Oct; 4(10):1583-8. PubMed ID: 26275572
[TBL] [Abstract][Full Text] [Related]
9. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.
Benish M; Bartal I; Goldfarb Y; Levi B; Avraham R; Raz A; Ben-Eliyahu S
Ann Surg Oncol; 2008 Jul; 15(7):2042-52. PubMed ID: 18398660
[TBL] [Abstract][Full Text] [Related]
10. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.
Cecilio HP; Valente VB; Pereira KM; Kayahara GM; Furuse C; Biasoli ÉR; Miyahara GI; Oliveira SHP; Bernabé DG
Cancer Chemother Pharmacol; 2020 Nov; 86(5):681-686. PubMed ID: 32980903
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
13. Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling.
Ricon I; Hanalis-Miller T; Haldar R; Jacoby R; Ben-Eliyahu S
Cancer; 2019 Jan; 125(1):45-56. PubMed ID: 30291805
[TBL] [Abstract][Full Text] [Related]
14. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.
McNamee EN; Ryan KM; Griffin EW; González-Reyes RE; Ryan KJ; Harkin A; Connor TJ
Brain Behav Immun; 2010 May; 24(4):660-71. PubMed ID: 20193756
[TBL] [Abstract][Full Text] [Related]
15. Propranolol Attenuates Surgical Stress-Induced Elevation of the Regulatory T Cell Response in Patients Undergoing Radical Mastectomy.
Zhou L; Li Y; Li X; Chen G; Liang H; Wu Y; Tong J; Ouyang W
J Immunol; 2016 Apr; 196(8):3460-9. PubMed ID: 26969754
[TBL] [Abstract][Full Text] [Related]
16. Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery.
Cash E; Sephton SE; Chagpar AB; Spiegel D; Rebholz WN; Zimmaro LA; Tillie JM; Dhabhar FS
Brain Behav Immun; 2015 Aug; 48():102-14. PubMed ID: 25728235
[TBL] [Abstract][Full Text] [Related]
17. The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.
Hazut O; Shaashua L; Benish M; Levi B; Sorski L; Benjamin B; Hoffman A; Zmora O; Ben-Eliyahu S
Int J Clin Pharmacol Ther; 2011 Sep; 49(9):545-54. PubMed ID: 21888867
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial.
Hüttner FJ; Rooman I; Bouche G; Knebel P; Hüsing J; Mihaljevic AL; Hackert T; Strobel O; Büchler MW; Diener MK
BMJ Open; 2020 Sep; 10(9):e040406. PubMed ID: 32998931
[TBL] [Abstract][Full Text] [Related]
19. "Don't let it to air": A cautionary tale of the potential consequences of surgery of residual cancer.
Tennakoon G; Auer R
Brain Behav Immun; 2023 Jul; 111():247-248. PubMed ID: 37127226
[TBL] [Abstract][Full Text] [Related]
20. Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers.
Hasegawa K; Torii Y; Ishii R; Oe S; Kato R; Udagawa Y
Arch Gynecol Obstet; 2011 Dec; 284(6):1515-21. PubMed ID: 21431842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
